![]() |
市场调查报告书
商品编码
1916642
眼部健康和视力支援产品市场预测至2032年:按产品类型、配方、通路、应用、最终用户和地区分類的全球分析Eye Health & Vision Support Products Market Forecasts to 2032 - Global Analysis By Product Type (Dietary Supplements, Vision Support Devices & Products, and Other Product Types), Formulation, Distribution Channel, Application, End User and By Geography |
||||||
根据 Stratistics MRC 的一项研究,预计到 2025 年,全球眼部健康和视力支援产品市场价值将达到 21.4 亿美元,到 2032 年将达到 35.1 亿美元,在预测期内的复合年增长率为 7.3%。
眼部健康和视力支援产品包括旨在促进健康视力和最佳眼部功能的消费者解决方案。此类别涵盖营养补充品、强化食品和饮料、眼部护理产品以及含有必需营养素和生物活性化合物的视力保护解决方案。这些产品旨在减轻眼部疲劳、缓解眼干、对抗电子萤幕照射并老龄化相关的视力衰退。透过支援日常眼部舒适度和长期眼部功能,我们满足了不同族群的预防性医疗保健需求。
预防性医疗保健的兴起
消费者越来越意识到定期眼部护理对于预防视力丧失和老龄化性眼科疾病的重要性。萤幕使用时间的增加、生活方式导致的眼睛疲劳以及视力障碍的早期出现,都促使人们积极采取营养补充和眼部保健措施。各国政府和医疗机构正在推广预防性视力检查和营养支援。诊断技术的进步使得眼科疾病的早期发现成为可能,进一步加强了预防措施。叶黄素、玉米黄素和Omega-3脂肪酸等功能性成分因其长期保护眼睛的作用而日益受到欢迎。这种预防导向的转变正在推动已开发市场和新兴市场持续成长。
缺乏长期临床证据
许多膳食补充剂依赖短期研究,而这些研究不足以充分证明其持久疗效。监管机构通常要求提供可靠的科学证据,这给产品核可和功效声明的证实带来了挑战。此外,由于研究结果因目标族群而异,一致性问题也日益受到关注。医疗保健专业人员可能不愿意推荐缺乏强而有力临床支援的产品。这种不确定性可能会降低消费者信心,并减缓产品的普及。因此,市场相关人员被迫投入大量资金进行研究,以提升产品的可信度。
个人化视力保健
基因组学、数位眼科诊断和人工智慧驱动的评估技术的进步,正推动着个人化眼科护理解决方案的实现。消费者越来越倾向于根据自身年龄、生活方式和特定视觉需求,寻求客製化的营养补充品和处方笺。穿戴式装置和行动应用程式正助力实现眼部健康的个人化监测。企业正利用数据分析,开发针对干眼症、蓝光照射和黄斑健康等疾病的专用产品。这种个人化服务提高了治疗效果和客户参与。随着精准医疗的扩展,个人化视力保健预计将变得越来越普及。
产品召回和品管问题
眼部保健品必须严格遵守安全和品质标准,以避免有害影响。污染、标籤不准确或成分品质波动都可能引发监管行动。产品召回不仅会造成经济损失,还会损害品牌声誉。全球对膳食补充剂生产的审查日益严格,并加大了合规压力。供应链的复杂性进一步增加了品管缺失的风险。如果没有健全的品管体系,企业可能会面临长期的信任危机。
新冠感染疾病对眼部健康和视力保护产品市场产生了复杂的影响。封锁措施和供应链中断暂时影响了生产和分销。眼科诊所的减少导致常规视力检查和诊断延误。然而,远距办公和线上教育导致萤幕使用时间增加,加剧了人们对眼睛疲劳的担忧。这促使消费者对眼部保健品和防护产品的需求增加。随着消费者转向线上购物,电子商务通路的重要性日益凸显。疫情过后,市场将聚焦在数位互动、市场韧性和预防性眼部护理解决方案。
预计在预测期内,膳食补充剂细分市场将占据最大的市场份额。
预计在预测期内,膳食补充剂领域将占据最大的市场份额。该领域受益于消费者的高接受度和日常服用的便利性。含有维生素、矿物质、类胡萝卜素和Omega-3脂肪酸的补充剂被广泛用于维护视力健康。人们对与老龄化相关的眼科疾病的认识不断提高,推动了稳定的市场需求。医疗保健趋势也促进了长期服用补充剂的趋势。胶囊、软糖和粉末等多种剂型的出现,也促进了其广泛应用。
预计在预测期内,线上药局领域将呈现最高的复合年增长率。
预计在预测期内,线上药局领域将实现最高成长率。网路普及率和智慧型手机使用量的不断提高,使得人们更容易存取数位健康平台。消费者更倾向于选择线上管道,因为其便利性、隐私和价格优势。订阅模式和宅配服务有助于提高客户维繫。线上平台也提供详细的产品资讯和使用者评价。远距医疗服务的整合进一步推动了线上购物的发展。
预计北美将在预测期内占据最大的市场份额。人们对眼部健康和预防保健的高度重视支撑了强劲的需求。该地区拥有成熟的营养保健品和膳食补充剂行业。与老龄化相关的视力障碍盛行率不断上升,推动了产品的普及。完善的法规结构确保了产品品质和消费者信心。眼科诊断技术的进步有助于早期疗育。
预计亚太地区在预测期内将实现最高的复合年增长率。快速的都市化和萤幕使用时间的增加导致视力相关问题日益增多。不断壮大的中产阶级人口增加了对健康和保健产品的支出。医疗基础设施的改善促进了产品的广泛普及。政府措施正在推动预防性医疗保健和提高营养意识。电子商务平台的扩张正在增强市场渗透率。
According to Stratistics MRC, the Global Eye Health & Vision Support Products Market is accounted for $2.14 billion in 2025 and is expected to reach $3.51 billion by 2032 growing at a CAGR of 7.3% during the forecast period. Eye Health & Vision Support Products encompass consumer-focused solutions formulated to promote healthy eyesight and optimal eye function. This category includes supplements, fortified foods and drinks, ocular care products, and vision protection solutions enriched with essential nutrients and bioactive compounds. These products are developed to reduce eye fatigue, manage dryness, counter digital screen exposure, and slow age-associated visual deterioration. By supporting daily eye comfort and long-term ocular performance, they cater to preventive care needs for diverse populations.
Rise of preventive healthcare
Consumers are increasingly aware of the importance of regular eye care in preventing vision impairment and age-related ocular conditions. Rising screen time, lifestyle-related eye strain, and early onset of vision disorders are encouraging proactive supplementation and eye wellness routines. Governments and healthcare organizations are promoting preventive vision screenings and nutritional support. Advances in diagnostic technologies are enabling early detection of eye conditions, further reinforcing preventive approaches. Functional ingredients such as lutein, zeaxanthin, and omega-3 fatty acids are gaining popularity for long-term eye protection. This shift toward prevention is driving sustained growth across both developed and emerging markets.
Lack of long-term clinical evidence
Many dietary supplements rely on short-duration studies that do not fully demonstrate sustained efficacy. Regulatory authorities often require robust scientific evidence, creating challenges for product approval and claims substantiation. Variability in study outcomes across populations also raises concerns about consistency. Healthcare professionals may hesitate to recommend products lacking strong clinical backing. This uncertainty can reduce consumer confidence and slow adoption rates. As a result, market players must invest heavily in research to strengthen credibility.
Personalized vision care
Advances in genomics, digital eye diagnostics, and AI-driven assessments are enabling tailored eye care solutions. Consumers are increasingly seeking customized supplements and formulations based on age, lifestyle, and specific vision needs. Wearable devices and mobile apps are supporting personalized monitoring of eye health. Companies are leveraging data analytics to develop targeted products for conditions such as dry eye, blue-light exposure, and macular health. This customization enhances treatment effectiveness and customer engagement. As precision healthcare expands, personalized vision care is expected to gain rapid traction.
Product recalls and quality control issues
Eye health supplements and products must adhere to strict safety and quality standards to avoid adverse effects. Contamination, inaccurate labeling, or inconsistent ingredient quality can trigger regulatory actions. Recalls not only result in financial losses but also damage brand reputation. Increasing global scrutiny on nutraceutical manufacturing is raising compliance pressure. Supply chain complexity further elevates the risk of quality lapses. Without robust quality control systems, companies may face long-term trust deficits.
The COVID-19 pandemic had a mixed impact on the eye health and vision support products market. Lockdowns and supply chain disruptions temporarily affected manufacturing and distribution. Reduced access to eye clinics delayed routine vision check-ups and diagnoses. However, increased screen exposure during remote work and online education heightened eye strain concerns. This led to growing consumer interest in eye supplements and protective products. E-commerce channels gained prominence as consumers shifted to online purchases. Post-pandemic, the market is focusing on digital engagement, resilience, and preventive eye care solutions.
The dietary supplements segment is expected to be the largest during the forecast period
The dietary supplements segment is expected to account for the largest market share during the forecast period. This segment benefits from high consumer acceptance and ease of daily consumption. Supplements containing vitamins, minerals, carotenoids, and omega-3s are widely used for maintaining vision health. Rising awareness of age-related eye disorders is fueling consistent demand. Preventive healthcare trends are encouraging long-term supplement usage. The availability of diverse formulations such as capsules, gummies, and powders supports broad adoption.
The online pharmacies segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the online pharmacies segment is predicted to witness the highest growth rate. Increasing internet penetration and smartphone usage are improving access to digital health platforms. Consumers prefer online channels for convenience, privacy, and competitive pricing. Subscription models and doorstep delivery are enhancing customer retention. Online platforms also provide access to detailed product information and reviews. The integration of teleconsultation services is further boosting online purchases.
During the forecast period, the North America region is expected to hold the largest market share. High awareness of eye health and preventive care supports strong demand. The region has a well-established nutraceutical and dietary supplement industry. Rising prevalence of age-related vision disorders is driving product adoption. Strong regulatory frameworks ensure product quality and consumer trust. Technological advancements in eye care diagnostics support early intervention.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. Rapid urbanization and increasing screen exposure are contributing to rising vision-related issues. Growing middle-class populations are spending more on health and wellness products. Improved healthcare infrastructure is supporting wider product availability. Government initiatives are promoting preventive healthcare and nutrition awareness. Expanding e-commerce platforms are enhancing market penetration.
Key players in the market
Some of the key players in Eye Health & Vision Support Products Market include Bausch & Lomb, Johnson & Johnson Vision, Pfizer Inc., EssilorLuxottica S.A., Vitabiotics Ltd., The Cooper Companies, The Nature's Bounty Co., Alcon Inc., Amway International, Nordic Naturals Inc., ZeaVision LLC, Blackmores Limited, Kemin Industries, Inc., NOW Foods, and Herbalife Nutrition Ltd.
In January 2026, Bausch + Lomb Corporation are launching its fifth annual fundraising challenge with Glaucoma Research Foundation (GRF) during Glaucoma Awareness Month in January. Bausch + Lomb will also sponsor The Glaucoma Foundation's (TGF) social media campaign to raise awareness of the disease and its impact by highlighting a glaucoma patient or advocate every day in January.
In December 2025, Pfizer Inc. announced it has entered into an exclusive global collaboration and license agreement with YaoPharma, a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Limited (02196.HK and 600196.SH), a leading innovation-driven global healthcare company, for the development, manufacturing and commercialization of YP05002, a small molecule glucagon-like peptide 1 (GLP-1) receptor agonist currently in Phase 1 development for chronic weight management.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.